• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.29% Nasdaq Down0.03%

    Supernus Pharmaceuticals, Inc. (SUPN)

    -NasdaqGM
    13.44 Up 0.18(1.36%) 4:00PM EDT
    |After Hours : 13.44 0.00 (0.00%) 4:25PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingMar 31, 2015Dec 31, 2014Sep 30, 2014Jun 30, 2014
    Total Revenue 28,133   30,801   52,488   29,675  
    Cost of Revenue1,618  2,282  1,321  1,661  
    Gross Profit 26,515   28,519   51,167   28,014  
    Operating Expenses
    Research Development3,683  5,770  4,657  4,677  
    Selling General and Administrative19,402  18,019  17,343  19,582  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss 3,430   4,730   29,167   3,755  
    Income from Continuing Operations
    Total Other Income/Expenses Net(2,070)814  (20)724  
    Earnings Before Interest And Taxes1,360  5,544  30,007  6,211  
    Interest Expense381  1,189  1,289  1,278  
    Income Before Tax979  4,355  28,718  4,933  
    Income Tax Expense62   -   -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(1,217)4,355  27,858  4,894  
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income 917   4,355   27,858   3,201  
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares 917   4,355   27,858   3,201  

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.